We are live on ! Find out more

717 hedge funds and large institutions have $38.9B invested in Aptiv in 2021 Q2 according to their latest regulatory filings, with 89 funds opening new positions, 295 increasing their positions, 240 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 295 | Existing positions reduced: 240

15% more capital invested

Capital invested by funds: $33.9B → $38.9B (+$4.98B)

5% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 85

0.31% more ownership

Funds ownership: 90.99%91.3% (+0.31%)

0% less funds holding

Funds holding: 720717 (-3)

7% less funds holding in top 10

Funds holding in top 10: 1413 (-1)

30% less call options, than puts

Call options by funds: $126M | Put options by funds: $180M

Holders
717
Holders Change
-3
Holders Change %
-0.42%
% of All Funds
12.43%
Holding in Top 10
13
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.14%
% of All Funds
0.23%
New
89
Increased
295
Reduced
240
Closed
85
Calls
$126M
Puts
$180M
Net Calls
-$54.1M
Net Calls Change
-$9.9M

APTV Hedge Fund Activity: Q2 2021 in Review

717 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Aptiv (APTV) for Q2 2021, worth a combined $38.9B — up 15% from $33.9B a quarter earlier.

Buyers outnumbered sellers: 89 funds opened new APTV positions and 85 closed out — a net gain of 4 holders — while 295 added to existing stakes and 240 trimmed.

The largest buyer was Macquarie Group, adding an estimated $226M. The largest seller was T. Rowe Price Associates, cutting an estimated $213M.

  • 717 institutional investors held Aptiv (APTV) as of Q2 2021, down from 720 in Q1 2021.
  • Funds reported $38.9B of Aptiv stock for Q2 2021, up 15% quarter-over-quarter.
  • 89 funds opened new Aptiv positions in Q2 2021 and 85 closed out, a net change of +4 holders.
  • The largest Aptiv buyer in Q2 2021 was Macquarie Group, an estimated $226M added.
  • The largest Aptiv seller in Q2 2021 was T. Rowe Price Associates, an estimated $213M sold.

Based on aggregated 13F filings for Q2 2021.